Safety of Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors for Advanced NSCLC.
J Thorac Oncol
; 18(2): e14-e16, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36682842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
Year:
2023
Document type:
Article
Affiliation country:
France